This page is part of the Da Vinci Payer Coverage Decision Exchange (PCDE) FHIR IG (v1.0.0: STU 1) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Use Cases and Overview

Current environment

Patients that move from one payer to another frequently experience interruptions or delays to existing care for chronic and acute conditions related to the inability of the new payer to obtain information about the ongoing treatment, understand its progress and verify the clinical need for such treatments. This frequently requires the patient or providers to change therapies, tolerate delays in care, see additional providers or schedule additional visits, and fill out or resubmit additional documentation showing that the care is medically necessary and appropriate. The process creates a significant burden on providers, add unnecessary costs, and introduces risk to the patient.

Background

The Healthcare industry in the US has recognized the need to support, where possible, continuity of care for both chronic and acute problems for individuals that move from one payer to another. The CMS NPRM on interoperability published in the Federal Register on March 3, 2019, requested input on requiring that payers be able to exchange clinical information from a prior payer to the current payer. The exchange of information is intended, as indicated in the preamble to the NPRM, to enable continuity of care as a member moves from one covered plan to another without:

1. forcing the member to pay for the care unless required as part of the change in plan coverage
2. have care terminated, or
3. requiring providers to submit additional documentation to the new plan that was already available to the prior plan.

The goal is to provide for continuity of care and to minimize provider burden.

In Scope

This Implementation Guide (IG) is focused on organizing and exchanging information from a prior payer associated with current treatments to allow the new payer to continue these treatments without placing an additional burden on either the member or the provider or creating interruptions in care.

Out-of-Scope

This implementation guide is not:

1. intended to define the exchange of information from any entity other than a prior payer to a current payer;
2. prescriptive on what information is required to substantiate medical necessity for any treatment;
3. expecting the exchange of plan proprietary guidelines; or
4. intended to fully automate the review and authorization process for continuity of care for the new payer for current treatments

Business Requirements

The goal of this implementation guide is to complement the payer data exchange implementation guide (PDex) by providing a framework in which a payer can indicate:

1. active treatment plans that a member is receiving,
2. conditions that led to the need for the active treatment plans,
3. guidelines that were used to evaluate the need for the care the patient is receiving,
4. prior authorizations that are in effect,
5. successes or failures of prior treatment that are relevant to the current treatment, (e.g. step therapies), and
6. the supporting clinical documentation that justifies the need for those specific treatments.

All of the information may not be available in a structured format (or capable of being represented in the named FHIR resources). However, the ability to indicate current problems, treatments, diagnoses, relevant guidelines, prior authorizations and associated clinical data as a coherent set of related information allows the new payer to review that information in light of the members need. They can then, where possible, use it to support the continuation of treatment for chronic or acute illnesses without forcing the existing provider or a new provider to submit additional documentation that is duplicative of information that is already available to the prior payer.

Clinical Requirements

Clinical requirements to support this implementation guide include the following:

1. the ability to define active treatment plans that are being provided to the member which include not just traditional treatments (e.g. home oxygen therapy for COPD. medications for management of diabetes) and their progress and the relevant providers of that care, but also participation in disease management programs to support a member’s chronic illnesses and help manage either specific clinical outcomes or quality of life;
2. conditions that led to the need for these treatments, such as: COPD - to indicating a need for home oxygen therapy, diabetes - basis for medication management of diabetes, organ transplant - indicating the need for immunosuppressants, etc.;
3. guidelines that are used to decide that such a treatment is appropriate. These can include commercial guidelines such as MCG, InterQual and others. The goal is to include a reference (e.g. URL) to the appropriate guideline;
4. any specific prior authorizations that are in effect to support the treatment such as authorization for home oxygen therapy, and
5. relevant clinical documentation that supports the need for the current therapy which may include, where appropriate, indications of prior therapies that have been tried and failed or have been considered and not pursued due to potential complications that are considered antecedent to the current therapy

Testing Requirements

This IG has been constructed in a manner that allows testing and validation - specifically:

• adherence to profiles defined in this guide
• adherence to profiles and communication patterns from referenced IGs such as PDex, CDex and HRex, and
• testing of conformance to the underlying FHIR standards for the associated release (e.g. FHIR R4).